An update on the discovery and development of reversible covalent inhibitors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics
Link
https://link.springer.com/content/pdf/10.1007/s00044-023-03065-3.pdf
Reference91 articles.
1. Roth GJ, Stanford N, Majerus PW. Acetylation of prostaglandin synthase by aspirin. PNAS. 1975;72:3073–6. https://doi.org/10.1073/pnas.72.8.307
2. Singh J, Petter RC, Baillie TA, Whitty A. The resurgence of covalent drugs. Nat Rev Drug Discov. 2011;10:307–17. https://doi.org/10.1038/nrd3410
3. Vita ED. 10 years into the resurgence of covalent drugs. Future Med Chem. 2021;13:193–210. https://doi.org/10.4155/fmc-2020-0236
4. Lonsdale R, Ward RA. Structure-based design of targeted covalent inhibitors. Chem Soc Rev. 2018;47:3816–30. https://doi.org/10.1039/C7CS00220C
5. Singh J. The ascension of targeted covalent inhibitors. J Med Chem. 2022;65:5886–901. https://doi.org/10.1021/acs.jmedchem.1c02134
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Trends in covalent drug discovery: a 2020–23 patent landscape analysis focused on select covalent reacting groups (CRGs) found in FDA-approved drugs;Expert Opinion on Therapeutic Patents;2024-09-11
2. Enzyme Inhibitors as Multifaceted Tools in Medicine and Agriculture;Molecules;2024-09-11
3. Advanced technologies for screening and identifying covalent inhibitors;TrAC Trends in Analytical Chemistry;2024-09
4. Towards imaging the immune state of cancer by PET: Targeting legumain with 11C-labeled P1-Asn peptidomimetics carrying a cyano-warhead;Nuclear Medicine and Biology;2024-09
5. Structural review of SARS-CoV-2 antiviral targets;Structure;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3